Clinical Trial Update: Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/Phase 3 study evaluating sorbitol with neoadjuvant chemotherapy plus Tirellizumab (PD-1 inhibitor) for locally ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastric Junction Adenocarcinoma

Drugs mentioned

• Sorbitol (sorbitol)
• Tirellizumab (Tirellizumab)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Gastric Junction Adenocarcinoma, Gastric Cancer | Phase 2, Phase 3 | Status: RECRUITING